- Active not recruitingPHASE3
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
This study compares a new cell therapy, called tisagenlecleucel, with standard treatments for adults with follicular lymphoma that has come back or not responded to previous therapies. We want to see if the new therapy can keep the lymphoma under control for longer.
For: Follicular Lymphoma (FL)Australia · Austria · Canada - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase II, single arm, multicenter open label trial to determine the efficacy and safety of tisagenlecleucel (CTL019) in adult patients with refractory or relapsed follicular lymphoma
This study is for adults in the UK with a type of cancer called follicular lymphoma that has come back or not responded to previous treatments. It investigates a new cell therapy called tisagenlecleucel to see how well it works and if it's safe.
For: Adult patients with refractory or relapsed follicular lymphomaItaly · Belgium · Germany